← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2019-01-25

Drug application

FDA Application #
ANDA211858
Application type
Abbreviated New Drug Application (Generic)
Brand name
MESALAMINE
Generic name
MESALAMINE
Active ingredients
MESALAMINE
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Marketing status
Prescription
Sponsor
SUN PHARM
Manufacturer
Sun Pharmaceutical Industries, Inc.
First approval
2019-01-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown